Edwards Lifesciences Income Tax Expense Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 112.87  0.84  0.75%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Income Tax Expense of Edwards Lifesciences Corporation with missing and latest data points interpolated. Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Income Tax Expense  10 Years Trend  
Increasing
Slightly volatile
 Income Tax Expense 
      Timeline 

Edwards Lifesciences Income Tax Expense Over Time

2015-12-31  127,500,000 
2016-12-31  168,400,000 
2017-12-31  155,736,842 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  104,128,070
Geometric Mean  63,820,697
Coefficient Of Variation  85.33
Mean Deviation  64,332,749
Median  96,700,000
Standard Deviation  88,853,866
Range  331,400,000
R Value  0.72
R Squared  0.52
Significance  0.008204
Slope  17,757,011

Currently Trending

V   
 NYQ 
Purchased over 20 shares of
few hours ago ago
Traded for 107.02
GOOG   
 NMS 
Purchased few shares of
few hours ago ago
Traded for 984.45
VMW   
 NYQ 
Purchased over 20 shares of
few hours ago ago
Traded for 117.4